Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,335 | -3,520 | -1,574 | -13,043 | -11,261 |
| Depreciation Amortization | 292 | 188 | 91 | 6,696 | 6,663 |
| Accounts receivable | 32 | 32 | 6 | 3 | 7 |
| Accounts payable and accrued liabilities | 134 | 120 | 19 | -294 | -149 |
| Other Working Capital | 25 | -143 | -116 | -578 | -286 |
| Other Operating Activity | 579 | 400 | 80 | 860 | 115 |
| Operating Cash Flow | $-4,273 | $-2,923 | $-1,494 | $-6,356 | $-4,911 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -351 | -179 | -2 | -12 | -8 |
| Investing Cash Flow | $-351 | $-179 | $-2 | $-12 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 3,326 | 3,326 |
| Debt Repayment | N/A | N/A | N/A | -1,246 | -1,246 |
| Common Stock Issued | 5,637 | 5,637 | 2,317 | 7,657 | 7,657 |
| Other Financing Activity | 0 | 0 | 0 | -707 | -707 |
| Financing Cash Flow | $5,637 | $5,637 | $2,317 | $9,031 | $9,031 |
| Beginning Cash Position | 2,741 | 2,741 | 2,741 | 78 | 78 |
| End Cash Position | 3,754 | 5,275 | 3,563 | 2,741 | 4,189 |
| Net Cash Flow | $1,013 | $2,535 | $822 | $2,663 | $4,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,273 | -2,923 | -1,494 | -6,356 | -4,911 |
| Capital Expenditure | -351 | -179 | N/A | -12 | -8 |
| Free Cash Flow | -4,624 | -3,102 | -1,494 | -6,368 | -4,919 |